BEUDAMED
    FDA Adverse Event Injury Summary report: N

    ECT

    MDR report key: 897552 · Received August 10, 2007

    Report

    Report Number
    MW5003411
    Event Type
    Injury
    Date Received
    August 10, 2007
    Date of Event
    July 1, 2004
    Report Date
    August 10, 2007
    Product Code
    GXC
    Adverse Event
    Yes
    Report Source
    Voluntary report
    Reporter Location
    CA, US
    Reporter Occupation
    PATIENT

    Narratives

    Description of Event or Problem · 1

    IN 2004, I WAS GIVEN ECT. AT NO TIME WAS I EVER INFORMED OF THE POSSIBLY I COULD SUSTAIN PERMANENT COGNITIVE DISABILITIES FROM THIS PROCEDURE. THE TREATMENTS WERE GIVEN 3 DAYS A WEEK TO START. WHEN I STOPPED THE TREATMENT IN LATE 2005, I WAS RECEIVING TREATMENTS EVERY OTHER WEEK. WHEN I REFUSED TO HAVE ANY MORE TREATMENTS, THE DR THREATENED TO PLACE ME IN A LONG RESIDENTIAL TREATMENT FACILITY. IN LATE 2006, I HAD NEUROPSYCHOLOGICAL TESTING WHICH SHOWED, I HAD LOST 22 POINTS ON MY IQ. I HAVE PROBLEMS WITH PROCESSING NEW INFO, ATTENTION PROBLEMS, SHORT TERM MEMORY PROBLEMS, I HAVE NO RECALL OF ANY EVENTS IN MY LIFE. I AM EASILY DISTRACTED, FORGOTTEN MY FAMILY MEMBERS AND FRIENDS, MY EDUCATION IS COMPLETELY ERASED. I AM HAVING TO RELEARN EVERYTHING I ONCE KNEW INCLUDING COOKING AND GROCERY SHOPPING, I AM CONSTANTLY GETTING LOST WHEN I GO SOMEPLACE. I HAVE LIVED IN THE SAME HOUSE FOR OVER 10 YRS AND HAVE FORGOTTEN MY NEIGHBORS. I CAN NO LONGER WORK AND ON PERMANENT DISABILITY DUE TO MY COGNITIVE PROBLEMS. DATES OF USE: 2004 - 2005. DIAGNOSIS OR REASON FOR USE: SEVERE DEPRESSION. EVENT ABATED AFTER USE STOPPED OR DOSE REDUCED? NO.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    1 ECT GXC

    Patients

    Seq Age Sex Outcome Treatment
    1 44 YR Required Intervention